ID1 and neuroblastoma: For NB treatment, Yu et al. conducted a clinical trial of GD2-mimicking anti-Id Ab 1A7 and showed little toxicity of anti-Id protein vaccines and effective induction of biologically active GD2-specific immune responses [1].